pioglitazone has been researched along with Temporomandibular Disorders in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Turosz, N | 1 |
| Chęcińska, K | 1 |
| Chęciński, M | 1 |
| Kamińska, M | 1 |
| Nowak, Z | 1 |
| Sikora, M | 1 |
| Chlubek, D | 1 |
| Henney, JE | 1 |
1 review available for pioglitazone and Temporomandibular Disorders
| Article | Year |
|---|---|
A Scoping Review of the Use of Pioglitazone in the Treatment of Temporo-Mandibular Joint Arthritis.
Topics: Animals; Arthritis, Rheumatoid; Inflammation; Pioglitazone; Temporomandibular Joint; Temporomandibul | 2022 |
1 other study available for pioglitazone and Temporomandibular Disorders
| Article | Year |
|---|---|
From the Food and Drug Administration.
Topics: Diabetes Mellitus, Type 2; Endotoxemia; Gentamicins; Humans; Hypoglycemic Agents; Joint Prosthesis; | 1999 |